Financial Performance - The company expects a net loss attributable to shareholders of between 1,000,000 and 1,300,000 RMB for the fiscal year 2024, compared to a profit of 2,653,930 RMB in the same period last year[3]. - The net profit after deducting non-recurring gains and losses is projected to be a loss of between 1,800,000 and 3,000,000 RMB, down from a profit of 797,150 RMB in the previous year[3]. - The decline in net profit is primarily due to adjustments in the medical information industry, increased customization demands, and extended project delivery and payment cycles, leading to a decrease in overall revenue and gross margin[5]. Strategic Development - The company is committed to a long-term development strategy, which includes increased investment in product research and development, impacting short-term net profit[6]. - Changes in the registered capital of the company's subsidiary, Liaoning Rongke Zhihui Cloud Technology Co., Ltd., have also affected the net profit attributable to shareholders[6]. Financial Reporting - The financial data provided is preliminary and has not been audited by the accounting firm, with further details to be disclosed in the 2024 annual report[7].
荣科科技(300290) - 2024 Q4 - 年度业绩预告